Discover trends, market shifts, and competitive outlooks for the acromegaly industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Acromegaly Market From 2025 To 2029?

In the past few years, the acromegaly market has seen swift expansion. This market, which is projected to increase from $2.15 billion in 2024 to $2.57 billion in 2025, will rise at a CAGR of 19.6%. The historic market expansion can be connected to factors such as the growing incidence of acromegaly therapeutics, heightened acromegaly awareness, government actions, and the demand for potent treatments.

The market size for acromegaly is anticipated to experience swift expansion in the ensuing years. The projected growth brings the worth to approximately $4.92 billion in 2029, with a CAGR of 17.6%. Towards this progression in the forecast period, factors attributed include increased investment in research and development for acromegaly cures, the growth in the number of screening initiatives, escalated spending on healthcare, and a mounting demand for low-risk treatment alternatives. The forecast period also foresees major trends such as the invention of unique treatments for acromegaly, the creation of specific therapies for the disorder, a robust drug pipeline, enhancements in treatment choices, and advances in personalized medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp

Which Primay Drivers Are Accelerating Growth in the Acromegaly Market?

The escalating prevalence of endocrine diseases like diabetes is anticipated to fuel the acromegaly market’s expansion. Endocrine disorders, essentially medical conditions resulting from an impaired endocrine system, are also classified as hormonal diseases. Diabetes ranks high within these diseases. Overproduction of certain hormones, like growth hormone or cortisol, could give rise to Acromegaly and other endocrine disorders. Furthermore, the overabundance of growth hormone might influence insulin synthesis, resulting in around 50% of acromegaly patients developing insulin resistance or Type-2 diabetes mellitus. To illustrate, information released by the UK’s Office for Health Improvement and Disparities in March 2024 revealed a substantial rise in the percentage of individuals receiving all eight suggested care procedures for type 1 and type 2 diabetes between March 2022 and 2023 (22% and 21% respectively), and an increased percentage (37.9%) of individuals reaching the target HbA1c levels, the highest figure ever reported by the National Diabetes Audit (NDA). Consequently, the rising cases of hormonal diseases are promoting the acromegaly market’s expansion. Another key driver for the acromegaly market’s growth is the surging instances of genetic abnormalities. Genetic aberrations, typically known as genetic defects, can lead to altered features, functions, or characteristics owing to changes in the DNA sequence within genes. Acromegaly often arises due to an overproduction of growth hormone by the pituitary gland, frequently stemming from benign adenomas, which can occur abruptly or be associated with specific genetic irregularities. As per data from the World Health Organization in February 2022, birth abnormalities cause the deaths of 240,000 newborns within their first 28 days of life each year, with an additional 170,000 casualties among 1-month to 5-year old children due to birth defects such as heart issues, neural tube defects, and Down syndrome. Therefore, the escalating prevalence of genetic defects is also bolstering the acromegaly market.

Which Primary Segments of the Acromegaly Market Are Driving Growth and Industry Transformations?

The acromegaly market covered in this report is segmented –

1) By Type: Ectopic Acromegaly, Acromegaly Due To Growth Hormone

2) By Diagnosis: GH And IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Treatment: Medication, Somatostatin analogues, Dopamine Agonists, Growth Hormone Antagonist, Surgery, Radiation, Other Treatments

5) By End Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Ectopic Acromegaly: Tumor-Induced Ectopic Acromegaly, Non-Tumor-Induced Ectopic Acromegaly

2) By Acromegaly Due To Growth Hormone: Primary Growth Hormone Excess, Secondary Growth Hormone Excess

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12913&type=smp

Which Regions Are Key Players in the Growth of the Acromegaly Market?

North America was the largest region in the acromegaly market in 2024. The regions covered in acromegaly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Acromegaly Industry Dynamics?

Major players in the acromegaly market are concentrating their efforts on creating cutting-edge products and solutions, such as generic lanreotide, to boost the range of treatments available and improve patient health outcomes. Generic lanreotide is simply an unbranded version of the medication used for treating acromegaly and some neuroendocrine tumors. It functions as a somatostatin analogue, diminishing growth hormone secretion and making effective treatment options more accessible for patients. For instance, Teva Pharmaceutical Industries Ltd., a company based in Israel and focused on generic drugs, rolled out the first and only generic version of Sandostatin LAR Depot in the United States in October 2024. The injectable suspension, known as octreotide acetate, is prescribed for treating acromegaly and severe diarrhea caused by carcinoid syndrome. This launch improves access to essential therapy for patients who need these treatments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report

What Parameters Are Used to Define the Acromegaly Market?

Acromegaly is a rare hormonal disorder that occurs when the pituitary gland, a small gland located at the base of the brain, produces excessive growth hormone. This excess growth hormone leads to the enlargement and thickening of bones and tissues in various body parts, particularly the hands, feet and face.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12913

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model